Clinical Trial Update: Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating long-term clinical efficacy of an SGLT-2 inhibitor in individuals with cystinuria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinuria

Drugs mentioned

• SGLT-2 inhibitor

Snippet

Sponsor: University of California, San Francisco | Conditions: Cystinuria | Phase 2 | Status: WITHDRAWN